Cancer research

Cancer research

Novel Computational Analysis Identifies Cytotoxic Lymphocyte-to-monocyte Balance in Tumors as a Predictor of Recurrence-free Survival in Colorectal Carcinoma

Researchers at the University of California San Francisco (UCSF) have made a groundbreaking discovery in the field of oncology, specifically in the study of colorectal cancer. By leveraging transcriptomic techniques, the team identified a specific immune cell population ratio that is strongly associated with cancer recurrence in colorectal cancer patients.

Cancer research

New Insights into Lung Cancer: FAT1 Mutation-Related Risk Signature Predicts Survival Risk and Tumor Immunogenicity

Researchers from Shandong, People's Republic of China, have made significant breakthroughs in understanding the relationship between FAT1 mutations and lung adenocarcinoma (LUAD). The study aimed to identify a FAT1 mutation-related transcriptomic risk signature to assess the survival risks and immune status of LUAD patients. The researchers collected a

Cancer research

Nanoparticle-Based Immunotherapy Shows Promise in Gastric Cancer Treatment

Researchers from Shandong Provincial Hospital and Shandong First Med Univ have made a groundbreaking discovery in the field of gastric cancer treatment. By leveraging nanoparticle-based immunotherapy, they have successfully targeted the CXCL12-CXCR4 signaling pathway, reprogramming tumor-associated macrophages to enhance anti-tumor immunity. This novel approach has shown significant promise in suppressing